ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02277522
Brief Title: CD19 Redirected Autologous T Cells for Hodgkin Lymphoma

First Submitted : October 27, 2014
First Submitted that Met QC Criteria : October 27, 2014
First Posted : October 29, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 7, 2017
Last Update Posted : November 9, 2017